Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-03-01 @ 6:29 AM
Study NCT ID:
NCT06581458
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-09-03
First Post:
2024-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Home Transcranial Direct-Current Stimulation for Motoric Cognitive Risk Syndrome
Sponsor:
Tel-Aviv Sourasky Medical Center
Organization:
Study Overview
Official Title:
Home Transcranial Direct-Current Stimulation for Motoric Cognitive Risk Syndrome
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HometDCS
Brief Summary:
1. To examine the effect of a two-week tDCS intervention of 3 months of continued tDCS intervention versus 3 months of receiving a placebo treatment (dummy). On the costs of performing an action task (dual task cost) walking speed, cognitive measures and motor function.
2. To examine whether the effects of tDCS build up over time by creating a delayed start mechanism in the intervention (delayed-start design)
3. Examining mechanical and neuroplastic effects of tDCS intervention
4. To examine the response to tDCS over time
2. To examine whether the effects of tDCS build up over time by creating a delayed start mechanism in the intervention (delayed-start design)
3. Examining mechanical and neuroplastic effects of tDCS intervention
4. To examine the response to tDCS over time
Detailed Description:
* The study aims to investigate the mechanical and neuroplastic effects of a tDCS intervention.
* The intervention consists of an initial two-week period of tDCS application, followed by three months of continued tDCS treatment.
* A placebo group will receive a dummy treatment for three months to compare the outcomes.
* The study will measure various parameters including the costs of performing an action task (dual task cost), walking speed, cognitive measures, and motor function.
* A delayed-start design will be used to determine if the effects of tDCS build up over time.
* The intervention consists of an initial two-week period of tDCS application, followed by three months of continued tDCS treatment.
* A placebo group will receive a dummy treatment for three months to compare the outcomes.
* The study will measure various parameters including the costs of performing an action task (dual task cost), walking speed, cognitive measures, and motor function.
* A delayed-start design will be used to determine if the effects of tDCS build up over time.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: